Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
5.65
0.00 (0.00%)
At close: Nov 26, 2025, 1:00 PM EST
5.63
-0.02 (-0.35%)
Pre-market: Nov 28, 2025, 6:16 AM EST
Evaxion Market Cap
Evaxion has a market cap or net worth of $46.91 million as of November 28, 2025. Its market cap has increased by 247.51% in one year.
Market Cap
46.91M
Enterprise Value
36.34M
1-Year Change
247.51%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $46.91M, a decrease of -75.57%. That is a compound annual growth rate of -25.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 46.91M | 845.93% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | 191.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |